Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-25 @ 2:41 AM
NCT ID:
NCT03739333
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 or over,
* Patient with glioblastoma treated by radiochemotherapy with temozolomide,
* Patient with suspicion of pseudoprogression between the 1st and 12th month after the end of concomitant chemoradiotherapy,
* Patient receiving a social security scheme,
* Patient for whom informed and written consent to participate has been obtained,
Exclusion Criteria:
* Subject under safeguard of justice (tutelage, curatorship),
* Minor patient,
* Patient without signs of progression MRI (stable disease or good response to treatment according to the RANO 2010 criteria),
* Clinical or radiological progression justifying a change of treatment,
* Patient not able to decide and with refusal of the family entitled to continue research.
* Pregnant woman, breastfeeding or old enough to have children but without effective contraception,
* Contraindication to performing an MRI: permanently fixed metal parts (pacemaker, cerebral clip, cochlear implant, pin or screw for recent bone fracture, dental equipment, metal splinters), claustrophobia,
* Contraindication to gadolinium according to ANSM 2017 recommendations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03739333
Study Brief:
Protocol Section:
NCT03739333